[Skip to Content]
[Skip to Content Landing]
August 28, 1967

Clinical Pharmacology and Experimental Therapeutics

Author Affiliations

Director, NIGMS Bethesda, Md

JAMA. 1967;201(9):705. doi:10.1001/jama.1967.03130090069025

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The critical commentary by Dr. John H. Moyer, (200:454, 1967) fails to present an accurate picture of the efforts to increase the numbers of trained clinical pharmacologists by the National Institutes of Health in general, and the National Institute of General Medical Sciences (NIGMS) in particular. We feel that it is essential to correct some of the misstatements of fact which he presented.Public Law 87-838, Section 442, provides for the establishment of the NIGMS for the "conduct and support of research and research training" in health-related sciences. Under this law the Institute may not support training in "drug testing" except as it may be an adjunct to other aspects of training for professional careers, nor does its mission include support for "drug screening" programs. Dr. Moyer's editorial manipulation of an alleged quotation of a NIGMS staff member makes it sound as though this legal restriction